p63 and p73 Signaling in Cell Growth and Cancer
细胞生长和癌症中的 p63 和 p73 信号转导
基本信息
- 批准号:8657362
- 负责人:
- 金额:$ 2.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdultBiologicalBiological ModelsBreastCancer Cell GrowthCancer PatientCarcinomaCell SurvivalCell modelCell physiologyCellsComplexDataData SetDevelopmentDevelopmental ProcessEpidermisEpithelialEpithelial CellsFamilyFamily memberFunctional disorderFundingGene ExpressionGene TargetingGenerationsGenetic TranscriptionGenotoxic StressGoalsHumanKnock-outKnockout MiceLaboratoriesLeadMalignant NeoplasmsMammary glandMesenchymalMetabolicMetabolic stressMetabolismMusNormal CellOrganPathway interactionsPlayPredispositionProcessProstateProtein FamilyProteinsProteomicsRegulationRelative (related person)RoleSignal PathwaySignal TransductionSkinStimulusStratum BasaleStressStructureTestingTherapeuticTimeTissuesTranslatingTumor SuppressionTumor Suppressor Proteinsbasecancer therapychromatin immunoprecipitationdesignexpectationgenetically modified cellsin vivo Modelinsightmouse modelnoveloverexpressionprotein complexprotein p73responsestoichiometrytumortumorigenesisubiquitin-protein ligase
项目摘要
Although the pivotal role of p53 in tumor suppression remains unchallenged, the role of its family members, p63 and p73 in normal cell function and tumorigenesis is far from certain. Structural similarities and functions of the p53 family of proteins connect them in similar signaling pathways, in both collaborative and antagonistic interactions; however, in vivo models suggest a role for both p63 and p73 in p53-independent developmental and differentiation processes. In particular, p63-null mice lack an epidermis and related structures such as mammary and prostate glands. Interestingly, p63 is expressed in the basal layer of several epithelial tissues such as skin, breast and prostate, and is overexpressed in many squamous and basal-like carcinomas. Evidence suggests that p63 may function in tumors in part through interaction with p73, which is also overexpressed in many human tumors. The goal of the proposed studies is to determine the roles of p63 and p73 in cell metabolism and survival as well as epithelial-mesenchymal crosstalk and transition, and to discover how these roles are deregulated during tumorigenesis. Through generation and integration of comprehensive chromatin immunoprecipitation and microarray data sets, we identified numerous novel p63 and p73 target genes. Based on our findings, we propose the following interrelated hypotheses: (i) p63 and p73 regulate the transcription of unique or shared target genes involved in cell metabolism and survival as well as epithelial-mesenchymal cross-talk and transition; and, (ii) loss of proper p63 and p73 activity will lead to altered cell survival and function resulting in developmental abnormalities or tumorigenesis, depending on the biological time point of dysfunction. These hypotheses will be tested through the following Specific Aims: (1) To analyze select novel target genes uniquely or coordinately regulated by p63 and p73. We will determine the role of these target genes in biologically relevant endpoints downstream of p63 and p73 signaling using organotypic model systems; (2) To analyze p63 and p73 protein complexes and a newly identified protein that interacts with these family members; and (3) To analyze mice with conditional, tissue-specific knock-out of p73. The mice will be characterized in terms of organ and metabolic function and response to stress. The effect of tissue-specific knockout of p63, p73, and p53, alone or in combination, in the mammary gland will be studied to determine the separate or coordinate roles of the family members in adult tissue function, and susceptibility to tumorigenesis. The importance of understanding p63 and p73 regulation and function is underscored by the deregulation of the p53 family in human tumors and the expectation that a mechanistic understanding of the p63 and p73 signaling axes in cancer will translate to therapeutic benefit for cancer patients.
尽管p53在肿瘤抑制中的关键作用仍然没有受到挑战,但其家族成员p63和p73在正常细胞功能和肿瘤发生中的作用还远未确定。 p53 蛋白家族的结构相似性和功能将它们通过相似的信号传导途径(无论是协作还是拮抗相互作用)连接起来;然而,体内模型表明 p63 和 p73 在独立于 p53 的发育和分化过程中发挥作用。特别是,p63缺失小鼠缺乏表皮和相关结构,例如乳腺和前列腺。有趣的是,p63在皮肤、乳腺和前列腺等多种上皮组织的基底层中表达,并且在许多鳞状细胞癌和基底样癌中过度表达。有证据表明,p63 可能部分通过与 p73 相互作用而在肿瘤中发挥作用,而 p73 在许多人类肿瘤中也过度表达。拟议研究的目标是确定 p63 和 p73 在细胞代谢和存活以及上皮-间质串扰和转变中的作用,并发现这些作用在肿瘤发生过程中如何失调。通过生成和整合全面的染色质免疫沉淀和微阵列数据集,我们鉴定了许多新的 p63 和 p73 靶基因。基于我们的发现,我们提出以下相互关联的假设:(i)p63和p73调节参与细胞代谢和存活以及上皮间质串扰和转变的独特或共享靶基因的转录; (ii) 适当的 p63 和 p73 活性的丧失将导致细胞存活和功能改变,从而导致发育异常或肿瘤发生,具体取决于功能障碍的生物学时间点。这些假设将通过以下具体目标进行检验:(1)分析由p63和p73独特或协调调节的选定新靶基因。我们将使用器官模型系统确定这些靶基因在 p63 和 p73 信号下游生物学相关终点中的作用; (2) 分析 p63 和 p73 蛋白复合物以及新鉴定的与这些家族成员相互作用的蛋白; (3) 分析条件性、组织特异性 p73 敲除的小鼠。这些小鼠的特征是器官和代谢功能以及对压力的反应。将研究p63、p73和p53单独或组合的组织特异性敲除在乳腺中的作用,以确定家族成员在成体组织功能和肿瘤发生易感性中的单独或协调作用。人类肿瘤中 p53 家族的失调以及对癌症中 p63 和 p73 信号轴的机制理解将转化为癌症患者的治疗益处的预期,强调了了解 p63 和 p73 调控和功能的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNIFER A PIETENPOL其他文献
JENNIFER A PIETENPOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNIFER A PIETENPOL', 18)}}的其他基金
The COVID-19 and Cancer Consortium: NCI Administrative Supplement to P30 Cancer Center Support Grant (CCSG)
COVID-19 和癌症联盟:NCI 对 P30 癌症中心支持补助金 (CCSG) 的行政补充
- 批准号:
10332040 - 财政年份:2021
- 资助金额:
$ 2.13万 - 项目类别:
Strategies to Improve Outcomes for triple negative Breast Cancer Patients involv
改善三阴性乳腺癌患者预后的策略包括
- 批准号:
8764758 - 财政年份:2014
- 资助金额:
$ 2.13万 - 项目类别:
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced Genomics
VANTAGE:整合创建范德比尔特先进基因组学技术
- 批准号:
7935727 - 财政年份:2010
- 资助金额:
$ 2.13万 - 项目类别:
相似国自然基金
基于生物三维打印的阿尔兹海默症炎性血脑屏障模型构建及β-淀粉样蛋白病变机制研究
- 批准号:52375295
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
具趋向性和非局部作用生物扩散模型的时空动力学研究
- 批准号:12301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脉络膜黑色素瘤循环血内肿瘤细胞的捕获、扩增、生物学特征分析与外泌体载药模型构建的研究
- 批准号:82303540
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于3D生物打印类器官模型探究PAK5调控三阴性乳腺癌铂类耐药的机制研究
- 批准号:82303979
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于微生物群落代谢网络模型构建解析客家黄酒发酵中扣囊复膜酵母与乳酸菌的交互作用机制
- 批准号:32302029
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
- 批准号:
10824044 - 财政年份:2024
- 资助金额:
$ 2.13万 - 项目类别:
Biomechanics of muscle after rotator cuff tear: Multi-scale assessment of spatial and temporal effects
肩袖撕裂后肌肉的生物力学:空间和时间影响的多尺度评估
- 批准号:
10556219 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing
生物工程经导管静脉瓣膜:设计优化和临床前测试
- 批准号:
10594865 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Mitochondrial Dysfunction Underlies the Integrated Stress Response Activation in Ponatinib-Induced Cardiotoxicity
线粒体功能障碍是帕纳替尼诱导的心脏毒性中综合应激反应激活的基础
- 批准号:
10735043 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别: